Literature DB >> 30656917

[Preeclampsia - a disease of pregnant women].

Anna Filipek1, Ewelina Jurewicz1.   

Abstract

Preeclampsia, also known as EPH-gestosis, is a pregnancy-specific syndrome. It affects 3-5% of pregnant women and is characterized by edemas, high blood pressure and proteinuria. Moreover, in women with preeclampsia dysfunction of many organs, such as kidney and liver, is diagnosed, while in the case of fetus growth restriction is observed. Preeclampsia, when left untreated, can lead to death. In low-income countries, this disorder is one of the main causes of maternal and child mortality. Preeclampsia predisposes women in later life to cardiovascular diseases. So far, in acute cases of preeclampsia stabilization of the mother and fetus and finally termination of pregnancy at a time optimal for both sides can only be considered. In this work, available literature data concerning the causes of preeclampsia, its symptoms, techniques for diagnosis, methods for prevention and new approaches to treatment were collected.

Entities:  

Mesh:

Year:  2018        PMID: 30656917     DOI: 10.18388/pb.2018_146

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  13 in total

1.  Genetic susceptibility analysis of FGF5 polymorphism to preeclampsia in Chinese Han population.

Authors:  Qian Xin; Ying Han; Wen Jiang; Jue Wang; Yun Luan; Qinghong Ji; Wenjuan Sun
Journal:  Mol Genet Genomics       Date:  2022-04-05       Impact factor: 3.291

2.  Clinical and Genetic Characteristics of Preeclampsia.

Authors:  O V Golovchenko; M Y Abramova; V S Orlova; I V Batlutskaya; I N Sorokina
Journal:  Arch Razi Inst       Date:  2022-02-28

3.  Fetal Cerebral Hemodynamic Changes in Preeclampsia Patients by Ultrasonic Imaging under Intelligent Algorithm.

Authors:  Di Zhu; Ru Ding; Hongxia Ma; Shenglin Jiang; Lijie Li
Journal:  Comput Intell Neurosci       Date:  2022-05-27

4.  Ubiquitin-Specific Peptidase 5 is Involved in the Proliferation of Trophoblast Cells by Regulating Wnt/β-Catenin Signaling.

Authors:  Liu Li; Shuo Wang; Ming Wang; Guoqing Qi; Hongliang Zhao
Journal:  Mol Biotechnol       Date:  2021-05-11       Impact factor: 2.695

5.  Identifying key genes and drug screening for preeclampsia based on gene expression profiles.

Authors:  Zhengfang Xu; Chengjiang Wu; Yanqiu Liu; Nian Wang; Shujun Gao; Shali Qiu; Zhutao Wang; Jing Ding; Lubin Zhang; Hui Wang; Weijiang Wu; Bing Wan; Jun Yu; Jie Fang; Peifang Yang; Qixiang Shao
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

6.  Tianma Gouteng Decoction Exerts Pregnancy-Protective Effects Against Preeclampsia via Regulation of Oxidative Stress and NO Signaling.

Authors:  Meiyuan Jin; Bin Cao; Chao Lin; Jiayong Li; Qiang Xu; Qianlei Ren; Shouying Xu; Chao Tang
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

Review 7.  The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Cielo García-Montero; Miguel A Sáez; Miguel Angel Álvarez-Mon; Diego Torres-Carranza; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla; Coral Bravo; Luis G Guijarro; Juan A De León-Luis
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

8.  Nested Case-Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia.

Authors:  Mei Liu; Rui-Bo Wang; Jian-Hong Xing; Ying-Xue Tang
Journal:  Int J Gen Med       Date:  2021-06-03

9.  LncRNA GASAL1 Interacts with SRSF1 to Regulate Trophoblast Cell Proliferation, Invasion, and Apoptosis Via the mTOR Signaling Pathway.

Authors:  Jia Liu; Qing Zhang; Nan Ma
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

10.  Increased FUN14 domain containing 1 (FUNDC1) ubiquitination level inhibits mitophagy and alleviates the injury in hypoxia-induced trophoblast cells.

Authors:  GuoQing Chen; Lu Chen; Yan Huang; XiongShan Zhu; YuanLan Yu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.